Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT
Clinical trial NCT04516551 · UNKNOWN
Trial details
- NCT number
- NCT04516551
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2021-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.